SGI
AMED

Summit Global Investments’s Amedisys AMED Stock Holding History

Summit Global Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-9,219
Closed -$1.38M – 540
2021
Q3 		$1.38M Sell
9,219
-10,538
-53% -$2.19M 0.1% 165
2021
Q2 		$4.84M Sell
19,757
-4,544
-19% -$1.19M 0.29% 73
2021
Q1 		$6.43M Sell
24,301
-2,796
-10% -$789K 0.41% 54
2020
Q4 		$7.95M Buy
27,097
+19,664
+265% +$5.04M 0.79% 32
2020
Q3 		$1.76M Buy
7,433
+433
+6% +$98.4K 0.18% 78
2020
Q2 		$1.39M Buy
+7,000
New +$1.31M 0.16% 94
2018
Q4 		– Sell
-8,400
Closed -$1.05M – 255
2018
Q3 		$1.05M Hold
8,400
– – 0.14% 107
2018
Q2 		$718K Sell
8,400
-1,400
-14% -$103K 0.11% 137
2018
Q1 		$591K Buy
+9,800
New +$558K 0.09% 149

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Summit Global Investments's AMED Position: Q4 2021 in Review

Summit Global Investments sold out of Amedisys (AMED) in Q4 2021, closing a stake of 9,219 shares — an estimated $1.38M sold.

Summit Global Investments first reported a position in AMED in Q1 2018 and held it in 9 quarters. The position peaked at $7.95M in Q4 2020. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Summit Global Investments reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Summit Global Investments sold 9,219 Amedisys shares in Q4 2021, an estimated $1.38M.
  • Summit Global Investments first reported a position in Amedisys in Q1 2018 and held it in 9 quarters.
  • Summit Global Investments's Amedisys position peaked at $7.95M in Q4 2020.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Summit Global Investments's 13F filing for Q4 2021, filed 14 Feb 2022.